The Pioneering Role of GATA2 in Androgen Receptor Variant Regulation Is Controlled by Bromodomain and Extraterminal Proteins in Castrate-Resistant Prostate Cancer

Molecular Cancer Research - United States
doi 10.1158/1541-7786.mcr-18-1231
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Crosstalk Between the Androgen Receptor and -Catenin in Castrate-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2008English

Regulation of the Transcriptional Coactivator FHL2 Licenses Activation of the Androgen Receptor in Castrate-Resistant Prostate Cancer

Cancer Research
Cancer ResearchOncology
2013English

Regulation of Tumor Cell Plasticity by the Androgen Receptor in Prostate Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2015English

The Role of GATA2 in Lethal Prostate Cancer Aggressiveness

Nature Reviews Urology
Urology
2016English

Evaluation of the Genomic Alterations in the Androgen Receptor Gene During Treatment With High-Dose Testosterone for Metastatic Castrate-Resistant Prostate Cancer

Oncotarget
Oncology
2020English

4-1bbl Has a Possible Role in Mediating Castration-Resistant Conversion of Prostate Cancer via Up-Regulation of Androgen Receptor

Journal of Cancer
Oncology
2019English

Guidelines for the Management of Castrate-Resistant Prostate Cancer

Journal of the Canadian Urological Association
OncologyUrology
2010English

Management of Docetaxel Failures in Metastatic Castrate-Resistant Prostate Cancer

Urologic Clinics of North America
Urology
2012English

Guidelines for the Management of Castrate-Resistant Prostate Cancer

Canadian Urological Association Journal
Urology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy